D.E. Shaw & Co
PRVA icon

D.E. Shaw & Co’s Privia Health PRVA Stock Holding History

D.E. Shaw & Co’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4M Buy
165,341
+125,056
+310% +$2.82M ﹤0.01% 2480
2025
Q4 		$955K Buy
40,285
+18,612
+86% +$453K ﹤0.01% 3573
2025
Q3 		$540K Buy
+21,673
New +$466K ﹤0.01% 3828
2023
Q1 		– Sell
-391,456
Closed -$8.89M – 4774
2022
Q4 		$8.89M Sell
391,456
-78,254
-17% -$2.18M 0.01% 1548
2022
Q3 		$16M Buy
+469,710
New +$17.4M 0.02% 1000

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co's PRVA Position: Q1 2026 in Review

D.E. Shaw & Co increased its Privia Health (PRVA) stake by 310% in Q1 2026, buying an estimated $2.82M and bringing the position to 165,341 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

D.E. Shaw & Co first reported a position in PRVA in Q3 2022 and has held it in 5 quarters since. The position peaked at $16M in Q3 2022. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • D.E. Shaw & Co held 165,341 shares of Privia Health worth $3.4M as of Q1 2026.
  • D.E. Shaw & Co bought 125,056 Privia Health shares in Q1 2026, an estimated $2.82M.
  • Privia Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2480 holding.
  • D.E. Shaw & Co first reported a position in Privia Health in Q3 2022 and has held it in 5 quarters since.
  • D.E. Shaw & Co's Privia Health position peaked at $16M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.